Kandace L. Amend

944 citations
12 papers · 410 indexed · h-index 7
Topics
Cervical Cancer and HPV Research (3 papers)Genital Health and Disease (2 papers)Hepatitis B Virus Studies (2 papers)

In The Last Decade

Kandace L. Amend

12 papers receiving 397 citations

Peers

Kandace L. Amend
Comparison fields: 5 of 77
  • Oncology 230
  • Cancer Research 99
  • Molecular Biology 99
  • Genetics 65
  • Pathology and Forensic Medicine 56
Replace Nava Siegelmann‐Danieli with:
Nava Siegelmann‐Danieli Israel
Elsa Curtit France
Hee-Chul Shin South Korea
Luca Livraghi Italy
Shanthi Sivendran United States
Nadeem Bilani United States
Lynn M. Neilson United States
Ekaphop Sirachainan Thailand
Manuela Tamburo De Bella Italy
Sayed Ali Australia
Kandace L. Amend relative to Nava Siegelmann‐Danieli Israel Nava Siegelmann‐Danieli's profile →
Citations per field
00.5×1.5×
Nava Siegelmann‐Danieli · 1×
Citations per year

Countries citing papers authored by Kandace L. Amend

Since Specialization
Citations

This map shows the geographic impact of Kandace L. Amend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kandace L. Amend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kandace L. Amend more than expected).

Fields of papers citing papers by Kandace L. Amend

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kandace L. Amend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kandace L. Amend. The network helps show where Kandace L. Amend may publish in the future.

Co-authorship network of co-authors of Kandace L. Amend

This figure shows the co-authorship network connecting the top 25 collaborators of Kandace L. Amend. A scholar is included among the top collaborators of Kandace L. Amend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kandace L. Amend. Kandace L. Amend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 4
2 1
3 2
4 1
5 8
6 4
7 46
8 36
9 30
10 78
11 153
12 47

About Kandace L. Amend

Kandace L. Amend is a scholar working on Oncology, Health and Epidemiology, having authored 12 papers that have together received 410 indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (3 papers), Genital Health and Disease (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Oncology (230 citations), Cancer Research (99 citations) and Pathology and Forensic Medicine (56 citations). Kandace L. Amend has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Christine B. Ambrosone, David G. Hicks, John D. Seeger, Tobias Kurth, Nadia Foskett, Pavel Napalkov, Joan Landon, Steve J. Niemcryk, Veena Thyagarajan and Andrew T. McAfee. Their work appears in journals such as Neurology, Cancer Research and Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026